Motzer RJ, et al. J Clin Oncol 36 (2018) (suppl 6S; abstr 578).
Pembrolizumab versus paclitaxel bij maagkanker
jul 2018 | Immuuntherapie, Maag-darm-leveroncologie
feb 2024 | Longoncologie
dec 2023 | Uro-oncologie
dec 2022 | Maag-darm-leveroncologie
jun 2021 | Chirurgie, Maag-darm-leveroncologie
feb 2021 | Maag-darm-leveroncologie
sep 2024
jul 2024
jun 2024
mrt 2024